A recent clinical study has proved that the increased risk of type 2 diabetes with statin treatment is associated with an impaired insulin sensitivity and insulin secretion.[6] Therefore, it is important to find out how to achieve an effective treatment outcome with statins without significantly affecting blood glucose or other atherosclerotic risk factors. The gene discussed is INS; the disease is type 2 diabetes mellitus.